Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Expert Committees
Advisory groups
Publications
All →
28 August 2025
Good practices for blood establishments
Blood transfusion is a vital component of modern health care and can be life-saving in many clinical situations. However, it is not without risks, including...
14 May 2025
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety:...
WHO recommends that essential medicines, including those that are controlled, be available to all patients at all times at a price that the individual...
23 April 2025
Guidance on implementing patient blood management to improve global blood health status
Incorporating expertise from peers working in countries where health care faces extreme resource constraints, attention is paid to how PBM processes...
16 April 2025
WHO Drug Information - Volume 39, No. 1
The first issue of volume 39 for 2025 includes:Consultation Documents: - "Aminosalicylate sodium dihydrate (aminosalicylatum natricum dihydricus)"- "Aminosalicylate...
Journal articles
The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
thebmj
Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception
National Library of Medicine
Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil
National Library of Medicine
